Investigational osteoporosis drug, abaloparatide, lowers fracture risk
Abaloparatide-SC, an injectable drug being studied for the treatment of postmenopausal osteoporosis, reduces the rate of new spinal fractures by a statistically significant 86 percent and as well as statistically significant ...
Mar 6, 2015
0
5